Gem Pharmaceuticals

About:

Gem Pharmaceuticals, LLC, is a clinical-stage biopharmaceutical company developing proprietary anthracycline derivatives specifically

Website: http://gempharmaceuticals.com

Top Investors: Diane Hendricks, Karl Leo

Description:

Gem Pharmaceuticals, LLC, is a clinical-stage biopharmaceutical company developing proprietary anthracycline derivatives specifically designed to eliminate the critical cardiotoxicity side effect of this powerful class of chemotherapeutics while maintaining their well-documented anti-cancer efficacy.

Total Funding Amount:

$4.5M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Birmingham, Alabama, United States

Founded Date:

2003-01-01

Founders:

Richard Olson

Number of Employees:

1-10

Last Funding Date:

2014-03-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai